|
RHOQ expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.665645482125E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.34740002383427E-09 |
| Normal-vs-Stage2 |
5.783600E-04 |
| Normal-vs-Stage3 |
9.754600E-04 |
| Normal-vs-Stage4 |
1.520440E-01 |
| Stage1-vs-Stage2 |
6.437500E-02 |
| Stage1-vs-Stage3 |
4.813800E-01 |
| Stage1-vs-Stage4 |
8.697200E-01 |
| Stage2-vs-Stage3 |
3.704000E-01 |
| Stage2-vs-Stage4 |
2.810400E-01 |
| Stage3-vs-Stage4 |
6.298400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.12279963104811E-10 |
| Normal-vs-AfricanAmerican |
1.97430000015153E-07 |
| Normal-vs-Asian |
1.900780E-01 |
| Caucasian-vs-AfricanAmerican |
9.858300E-02 |
| Caucasian-vs-Asian |
7.934000E-01 |
| AfricanAmerican-vs-Asian |
7.355800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.03310027199655E-10 |
| Normal-vs-Female |
3.30079996668786E-09 |
| Male-vs-Female |
2.758400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.618200E-04 |
| Normal-vs-Extreme_Weight |
7.07939999955443E-07 |
| Normal-vs-Obese |
1.34519999994698E-06 |
| Normal-vs-Extreme_Obese |
1.200390E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.174600E-01 |
| Normal_Weight-vs-Obese |
9.433000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.053000E-01 |
| Extreme_Weight-vs-Obese |
3.178800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.248000E-01 |
| Obese-vs-Extreme_Obese |
8.475000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.537600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.42910128175799E-11 |
| Normal-vs-Age(61-80Yrs) |
2.1540999983749E-08 |
| Normal-vs-Age(81-100Yrs) |
1.435590E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.530600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.977000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.603800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.137700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.190000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.716400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.04749550647421E-11 |
| Normal-VS-Type2 PRCC |
8.67599999954116E-07 |
| Normal-VS-KIRP CIMP |
4.121200E-01 |
| Normal-VS-Unclassified PRCC |
1.78457999999715E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.675400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.332550E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.031610E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.541810E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.467800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.904100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.004500E-03 |
| Normal-vs-N1 |
8.181500E-03 |
| Normal-vs-N2 |
1.307980E-01 |
| N0-vs-N1 |
3.931800E-01 |
| N0-vs-N2 |
6.659600E-01 |
| N1-vs-N2 |
9.969000E-01 |
|
|
